Techcyte partner NanoSpot.ai announces partnership with Opto to commercialize SARS-CoV-2 Antibody Test in Europe
OREM, UT, UNITED STATES, September 19, 2022 /EINPresswire.com/ -- Techcyte, the clinical pathology AI platform, is proud to congratulate its partner, NanoSpot.ai, on entering into a commercial and distribution agreement with Opto, an Athroa company and …